Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

CompletedOBSERVATIONAL
Enrollment

174

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

October 25, 2019

Study Completion Date

October 25, 2019

Conditions
Glaucoma
Interventions
DEVICE

XEN Group

Chart review was conducted in participants with open angle glaucoma who underwent placement of the implant XEN 45 Gel Stent as a standalone procedure from 1 January 2014 to 1 October 2015.

PROCEDURE

Phacoemulsification

Chart review was conducted in participants with open angle glaucoma who underwent placement of the implant XEN 45 Gel Stent in combination with phacoemulsification (Phaco) from 1 January 2014 to 1 October 2015.

Trial Locations (1)

92622

Clinical Trials Registry Team, Irvine

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY